SYNRIAMTM is now a single treatment for both Plasmodium vivax and Plasmodium falciparum malaria

About SynriamTM

SYNRIAMTM is a fixed dose combination of arterolane with piperaquine, developed as simplified once-a-day… Read More

What Causes Malaria

Malaria is an infection of the blood caused by parasites. It spreads through the bite of the infected female anopheles mosquito. There are four types of malarial parasites… Read More


Mr. Arun Sawhney, CEO & MD,
Ranbaxy


This is indeed a proud moment for drug research in India and for Ranbaxy, as it launches India’s first new drug, SynriamTMRead More

Mr. Ghulam Nabi Azad, Minister of Health & Family Welfare, Govt. of India


I am delighted to know that Ranbaxy Laboratories Limited has indigenously developed a new drug for Malaria that is among the… Read More

Late Mr. Vilasrao Deshmukh, Minister of Science & Technology and Earth Sciences, Govt. of India

The world observes 25 April as World Malaria Day. The disease biology of malaria is more manifested in tropical environments…. Read More

(SynriamTM is a prescription product and should only be taken on Doctor’s advice)